SAVOLDI, Daria
 Distribuzione geografica
Continente #
NA - Nord America 414
EU - Europa 165
AS - Asia 83
SA - Sud America 1
Totale 663
Nazione #
US - Stati Uniti d'America 412
UA - Ucraina 62
CN - Cina 59
IT - Italia 27
DE - Germania 24
FI - Finlandia 22
HK - Hong Kong 14
IE - Irlanda 11
FR - Francia 9
GB - Regno Unito 8
IN - India 5
CA - Canada 2
IR - Iran 2
BR - Brasile 1
IL - Israele 1
JP - Giappone 1
PL - Polonia 1
RO - Romania 1
TR - Turchia 1
Totale 663
Città #
Fairfield 50
Jacksonville 45
Houston 44
Chandler 37
Ann Arbor 32
Woodbridge 24
Ashburn 23
Cambridge 22
Princeton 20
Brescia 17
Seattle 16
Wilmington 16
Nanjing 15
Helsinki 14
Hong Kong 14
New York 14
Beijing 12
Dublin 11
Dearborn 9
Hebei 5
Jiaxing 4
Lancaster 4
Nanchang 4
Boardman 3
Changsha 3
Des Moines 3
San Diego 3
San Mateo 3
Shenyang 3
Ardabil 2
Hangzhou 2
Jinan 2
Kunming 2
Leawood 2
Milan 2
Tianjin 2
Toronto 2
Verona 2
Alexandria 1
Augusta 1
Cagliari 1
Cupertino 1
Frankfurt am Main 1
Hefei 1
Monmouth Junction 1
Ningbo 1
Orange 1
Paris 1
Phoenix 1
Prescot 1
Pune 1
San Donà Di Piave 1
Shanghai 1
São Paulo 1
Tokyo 1
Warsaw 1
Zhengzhou 1
Totale 507
Nome #
Shp-2 knockdown prevents l-dopa-induced dyskinesia in a rat model of Parkinson's disease 123
Persistent activation of the D1R/Shp-2/Erk1/2 pathway in L-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease 119
Receptor Heteromers in Parkinson's Disease and L-DOPA-Induced Dyskinesia 107
Dopamine D1R activation triggers Erk1/2 activation in striatal neurons through the interaction with the protein tyrosine phosphatase Shp-2. 63
Down-regulation of the D1R/Shp-2/Erk1/2 pathway ameliorates L-DOPA-induced dyskinesia in the 6-Hydroxy-Dopamine rat model of Parkinson's disease. 63
In-vivo silencing of the tyrosine phosphatase Shp-2 ameliorates L-DOPA-induced dyskinesia in a rat model of Parkinson’s disease 61
Molecular mechanisms underlying dopamine D1R-dependent activation of striatal Erk1/2 in L-DOPA induced dyskinesia in a rat model of Parkinson’s disease. 55
Role of dopamine D1 receptor and phosphatase Shp-2 in L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. 51
Knock-down of the tyrosine phosphatase Shp-2 ameliorates L-DOPA-induced dyskinesia in a rat model of parkinson's disease. 51
Kounis syndrome, a disease to know: Case report and review of the literature 14
Totale 707
Categoria #
all - tutte 3.023
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.023


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201930 0 0 0 0 0 0 0 0 0 0 15 15
2019/2020167 28 4 4 18 6 20 18 19 13 18 9 10
2020/2021103 1 11 1 11 0 12 1 14 17 12 22 1
2021/202268 3 14 2 0 0 1 2 2 4 16 5 19
2022/202387 10 1 1 6 11 25 0 8 19 1 4 1
2023/202467 7 2 8 9 4 19 2 2 14 0 0 0
Totale 707